Effects of renin–angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Effects of renin–angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis

Published:2012-04 Issue:1 Volume:96 Page:68-75
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Nakao Yoko M.,Teramukai Satoshi,Tanaka Sachiko,Yasuno Shinji,Fujimoto Akira,Kasahara Masato,Ueshima Kenji,Nakao Kazuhiro,Hinotsu Shiro,Nakao Kazuwa,Kawakami Koji

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference41 articles.

1. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease;Kunz;Ann Intern Med,2008

2. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials;Turnbull;Arch Intern Med,2005

3. Ongoing safety review of Benicar and cardiovascular events;FDA Drug Safety Communication,2010

4. Effect of inhibitors of the renin–angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis;Casas;Lancet,2005

5. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT);Whelton;Arch Intern Med,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization;Aging Cell;2022-03-27

2. Meta-analysis of impact of renin-angiotensin system inhibitors on survival after transcatheter aortic valve implantation;Minerva Cardiology and Angiology;2021-07

3. Impacto de los inhibidores del sistema renina-angiotensina en el pronóstico tras recambio valvular aórtico quirúrgico o percutáneo. Metanálisis;Revista Española de Cardiología;2021-05

4. Impact of renin-angiotensin system inhibitors on outcomes after surgical or transcatheter aortic valve replacement. A meta-analysis;Revista Española de Cardiología (English Edition);2021-05

5. Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice;Current Vascular Pharmacology;2020-01-27